These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


405 related items for PubMed ID: 12395219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
    Perrot A, Osterziel KJ, Beck M, Dietz R, Kampmann C.
    Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anderson-Fabry disease and the heart.
    O'Mahony C, Elliott P.
    Prog Cardiovasc Dis; 2010 Nov; 52(4):326-35. PubMed ID: 20109602
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Many Faces of Fabry's Cardiomyopathy.
    Jain R, Kalvin L, Johnson B, Muthukumar L, Khandheria BK, Tajik AJ.
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):644-647. PubMed ID: 29361493
    [No Abstract] [Full Text] [Related]

  • 9. Natural history of the cerebrovascular complications of Fabry disease.
    Mehta A, Ginsberg L, FOS Investigators.
    Acta Paediatr Suppl; 2005 Mar; 94(447):24-7; discussion 9-10. PubMed ID: 15895708
    [Abstract] [Full Text] [Related]

  • 10. [Diagnosis of Fabry disease: usefulness of the clinical investigation].
    Demontis R.
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S229-32. PubMed ID: 21211670
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiac manifestations of Anderson-Fabry disease in heterozygous females.
    Kampmann C, Baehner F, Whybra C, Martin C, Wiethoff CM, Ries M, Gal A, Beck M.
    J Am Coll Cardiol; 2002 Nov 06; 40(9):1668-74. PubMed ID: 12427421
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study.
    Madsen CV, Bundgaard H, Rasmussen ÅK, Sørensen SS, Petersen JH, Køber L, Feldt-Rasmussen U, Petri H.
    Scand Cardiovasc J; 2017 Aug 06; 51(4):207-216. PubMed ID: 28545342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
    Maron MS, Xin W, Sims KB, Butler R, Haas TS, Rowin EJ, Desnick RJ, Maron BJ.
    Am J Med; 2018 Feb 06; 131(2):200.e1-200.e8. PubMed ID: 28943383
    [Abstract] [Full Text] [Related]

  • 18. Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy.
    Frustaci A, Chimenti C, Ricci R, Natale L, Russo MA, Pieroni M, Eng CM, Desnick RJ.
    N Engl J Med; 2001 Jul 05; 345(1):25-32. PubMed ID: 11439944
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Fabry disease in cardiology: Diagnosis and therapeutic approaches].
    Çavuşoğlu Y, Özpelit E, Arslan N, Demir M, Kahveci G, Onay H, Ökçün EÖB, Tufekcioglu O, Tülüce SY, Yıldırım GK.
    Turk Kardiyol Dern Ars; 2020 Dec 05; 48(Suppl 2):1-42. PubMed ID: 33476309
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.